SCHEMBL27758897

SCHEMBL27758897

CC(C)(Cc1ccccc1CI)OC(N)=O

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CTSK P43235 2/20 0.35
▸ CYP3A4 P08684 2/20 0.33
▸ CYP2C19 P33261 2/20 0.33
▸ CYP1A2 P05177 2/20 0.33
▸ CYP2D6 P10635 2/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ NFKB1 P19838 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ PMP22 Q01453 1/20 0.33
▸ NLRP3 Q96P20 1/20 0.33
▸ HIF1A Q16665 1/20 0.33
▸ AKT1 P31749 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ PKM P14618 1/20 0.30
▸ SMN1; SMN2 Q16637 1/20 0.30
▸ NPSR1 Q6W5P4 1/20 0.30
▸ IDO1 P14902 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27586113 0.87 GABRA1 (0.39) CTSKCYP3A4CYP2C19CYP1A2CYP2D6
SCHEMBL27837868 0.85 SMN1; SMN2 (0.39) CTSKCYP3A4CYP2C19CYP1A2CYP2D6
SCHEMBL27737954 0.85 CYP4F2 (0.41) CTSKCYP3A4CYP2C19CYP1A2CYP2D6
SCHEMBL27839098 0.84 CTSK (0.35) CTSKCYP3A4CYP2C19CYP1A2CYP2D6
SCHEMBL27500366 0.82 FDPS (0.46) CTSKCYP3A4CYP2C19CYP1A2CYP2D6
SCHEMBL28272597 0.82 NR3C2 (0.43) CTSKKMT2ALMNAALDH1A1
SCHEMBL27852818 0.81 RIPK1 (0.43) CTSKMAPTKMT2ALMNAALDH1A1
SCHEMBL27668919 0.81 ALDH1A1 (0.47) CTSKKMT2ALMNAALDH1A1IDO1
SCHEMBL27724270 0.80 CYP3A4 (0.35) CYP3A4CYP2C19CYP1A2CYP2D6CYP2C9
SCHEMBL28183309 0.77 L3MBTL1 (0.47) CYP1A2CYP2C9MAPTKMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101421256-A Thiadiazolidinone inhibitors of ptpase NOVARTIS AG (CH) 2009-04-29 — — CN disclosed
Send feedback